A subscription to JoVE is required to view this content. Sign in or start your free trial.
Abstract
Medicine
ERRATUM NOTICE
Important: There has been an erratum issued for this article. Read more …Dilated cardiomyopathy (DCM) refers to a spectrum of heterogeneous myocardial disorders characterized by ventricular dilation and depressed cardiac performance in the absence of hypertension, valvular, congenital, or ischemic heart diseases, and which may be related to infection, autoimmune or metabolic abnormalities, or family inheritance. It can progress into congestive heart failure with a poor prognosis. Doxorubicin (Dox) is widely employed as a chemotherapeutic drug, but its use is limited because it causes DCM-like changes of the myocardium. Its myocardial toxicity is attributed to oxidative stress, chronic inflammation, and cardiomyocyte apoptosis. A model of DCM exploiting these Dox-induced DCM symptoms has not been established.
Erratum
Erratum: A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In VivoAn erratum was issued for: A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo. A figure was updated.
Figure 1 was updated from:
Figure 1: Schematic diagram of a Dox-induced dilated cardiomyopathy. Please click here to view a larger version of this figure.
to:
Figure 1: Schematic diagram of a Dox-induced dilated cardiomyopathy. Please click here to view a larger version of this figure.
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved